We are live on ! Find out more
TARA icon

Protara Therapeutics
TARA

33 hedge funds and large institutions have $118M invested in Protara Therapeutics in 2020 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 13 increasing their positions, 4 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

225% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 4

71% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 7

27% more capital invested

Capital invested by funds: $92.3M → $118M (+$25.2M)

18% more funds holding

Funds holding: 28 → 33 (+5)

0.1% more ownership

Funds ownership: 67.71% → 67.81% (+0.1%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
33
Holders Change
+5
Holders Change %
+17.86%
% of All Funds
0.68%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
12
Increased
13
Reduced
4
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BlackRock
BlackRock
New York
+$2.84M
2
IC
Ikarian Capital
Texas
+$2.39M
3
State Street
State Street
Massachusetts
+$562K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$540K
5
Northern Trust
Northern Trust
Illinois
+$512K

Top Sellers

1
DS
DRW Securities
Illinois
-$3.07M
2
A
Abingworth
United Kingdom
-$1.87M
3
Millennium Management
Millennium Management
New York
-$1.03M
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$441K
5
Goldman Sachs
Goldman Sachs
New York
-$352K
Name Holding Trade Value Shares
Change 		Change in
Stake
OM
1
Opaleye Management
Massachusetts
$64.8M – – –
IC
2
Ikarian Capital
Texas
$15.5M +$2.39M +77,192 +17%
DM
3
Deerfield Management
New York
$12.7M – – –
BC
4
Boxer Capital
California
$6.13M +$299K +9,660 +5%
BBA
5
Baker Bros. Advisors
New York
$5.85M – – –
A
6
Abingworth
United Kingdom
$3M -$1.87M -60,307 -53%
BlackRock
7
BlackRock
New York
$2.71M +$2.84M +91,674 +12,912%
EP
8
Eversept Partners
New York
$1.36M +$428K +13,832 +43%
BFM
9
Boothbay Fund Management
New York
$1.29M +$220K +7,091 +19%
Renaissance Technologies
10
Renaissance Technologies
New York
$879K +$127K +4,100 +16%
State Street
11
State Street
Massachusetts
$532K +$562K +18,157 New
Geode Capital Management
12
Geode Capital Management
Massachusetts
$511K +$540K +17,444 New
Vanguard Group
13
Vanguard Group
Pennsylvania
$510K +$254K +8,211 +89%
Northern Trust
14
Northern Trust
Illinois
$485K +$512K +16,523 New
Millennium Management
15
Millennium Management
New York
$271K -$1.03M -33,189 -78%
Wells Fargo
16
Wells Fargo
California
$257K +$268K +8,657 +8,167%
HF
17
HRT Financial
New York
$215K +$227K +7,339 New
DMK
18
David M. Knott
$112K +$37.1K +1,200 +46%
Bank of America
19
Bank of America
North Carolina
$104K -$140K -4,535 -56%
New York State Common Retirement Fund
20
New York State Common Retirement Fund
New York
$94K +$99.1K +3,200 New
California State Teachers Retirement System (CalSTRS)
21
California State Teachers Retirement System (CalSTRS)
California
$89K +$94.1K +3,040 New
JP Morgan Chase
22
JP Morgan Chase
New York
$45K +$40K +1,292 +513%
AIG
23
American International Group
New York
$36K +$38.2K +1,233 New
Deutsche Bank
24
Deutsche Bank
Germany
$27K +$28.7K +928 New
UBS Group
25
UBS Group
Switzerland
$20K +$9.22K +298 +80%
1
2

TARA Hedge Fund Activity: Q2 2020 in Review

33 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Protara Therapeutics (TARA) for Q2 2020, worth a combined $118M — up 27% from $92.3M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new TARA positions and 7 closed out — a net gain of 5 holders — while 13 added to existing stakes and 4 trimmed.

The largest buyer was BlackRock, adding an estimated $2.84M. The largest seller was DRW Securities, exiting entirely with an estimated $3.07M sold.

  • 33 institutional investors held Protara Therapeutics (TARA) as of Q2 2020, up from 28 in Q1 2020.
  • Funds reported $118M of Protara Therapeutics stock for Q2 2020, up 27% quarter-over-quarter.
  • 12 funds opened new Protara Therapeutics positions in Q2 2020 and 7 closed out, a net change of +5 holders.
  • The largest Protara Therapeutics buyer in Q2 2020 was BlackRock, an estimated $2.84M added.
  • The largest Protara Therapeutics seller in Q2 2020 was DRW Securities, an estimated $3.07M sold.

Based on aggregated 13F filings for Q2 2020.